1<!DOCTYPE html>

» Products & Services » » Medical Affairs » Structure, Staffing and Budgets

Preparing Medical Affairs for a Changing Environment: Structure, Staffing, Budget & Performance Measurement Trends

ID: 5285


16 Info Graphics

22 Data Graphics

475 Metrics

3 Narratives

Pages/Slides: 49

Published: Pre-2016

Delivery Format: Online PDF Document


License Options:

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.

Buy Now


Non-members: Click here to review a complimentary excerpt from "Preparing Medical Affairs for a Changing Environment: Structure, Staffing, Budget & Performance Measurement Trends."

Study Overview

The Medical Affairs function plays a critical role in not only working with thought leaders but also in dealing with a wide range of stakeholders who influence market access. Internal and external pressures have led to significant changes in the following areas within
Medical Affairs:  Structure & Leadership, Budgeting & Staffing, and Performance Metrics.

Best Practices, LLC conducted this benchmarking study to provide Medical Affairs' leadership with critical comparative data, performance metrics, and best practices that they can use to assess their operations across these important operational fronts.

Key Topics

  • Scope & Structure 
  • Leadership & Oversight 
  • Spend Allocation & Staffing     
  • Budget Trends & Outsourcing                 
  • Performance Metrics 

Sample Key Metrics
  • Number of Therapeutic Areas & Compounds/Products Supported by Medical Affairs
  • Current Structure of Medical Affairs
  • Leadership Structure of Medical Affairs' Functions
  • Job Level of Heads of Medical Affairs' Functions
  • Percentage of Total Medical Affairs Spend Allocated In Mature Markets
  • Percentage of Total Medical Affairs FTEs Staffed In Various Functions in Mature Markets
  • Percentage of Total Medical Affairs Spend Allocated in Emerging Markets
  • Percentage of Total Medical Affairs FTE Staffed In Various Functions in Emerging Markets
  • Trends of Important FTE Allocation Areas in Mature Markets
  • Trends of Important FTE Allocation Areas in Emerging Markets
  • Reasons for Change in Spend & FTEs Within Medical Affairs' Functions
  • Resource Level Changes in Mature & Emerging Markets
  • Outsourcing Expenses In Mature & Emerging Markets
  • Metrics & Tools Used for Evaluating the Performance of Medical Affairs' Organizations
  • Evaluation Frequency of Performance Metrics in Mature & Emerging Markets
  • Importance of Performance Metrics for Conveying Functional Value in Mature & Emerging Markets
  • Number of FTEs in Medical Affairs' Emerging & Mature Markets
  • Geographic Span of Responsibility of Medical Affairs

Sample Key Finding
  • Tools & Technology & Chat: 55% of the Mature Market participants and 50% of the Emerging Markets participants indicated that Medical Affairs' geographic span of responsibility is global, including the U.S..
Study Methodology

This study engaged executives from 30 leading healthcare companies. Segmentation analysis was key to examining trends and effective practices. 22 participants make up the Mature Markets Segment, while the Emerging Markets Segment consists of 6 participants from Brazil, India and other Asia markets.  The Medical Device Segment consists of 9 participants. This report includes Mature and Emerging Markets segments’ analysis.

Industries Profiled:
Health Care; Pharmaceutical; Biotech; Biopharmaceutical; Clinical Research; Laboratories; Medical Device; Chemical

Companies Profiled:
Sanofi; Covidien; ProStrakan; Upsher-Smith; Teva Pharmaceutical Industries Ltd; Genentech; AstraZeneca; Merck; Amgen; Acorda Therapeutics; Crescendo Bioscience; Kadmon Pharmaceuticals; Ironwood; Baxter Healthcare; United Therapeutics; Biogen Idec; Astellas; Pierre Fabre Medicament; Cubist Pharmaceuticals; Biocon; Dr Reddy's Laboratories; Shire

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.